Recent News

• 03.03.2025 - Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
• 03.03.2025 - Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
• 02.19.2025 - Predictive Oncology Closes Registered Direct Offering
• 02.19.2025 - Predictive Oncology Closes Registered Direct Offering
• 02.19.2025 - Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
• 02.19.2025 - Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
• 02.18.2025 - Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing
• 02.18.2025 - Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing
• 02.10.2025 - Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
• 02.10.2025 - Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis

Recent Filings

• 02.19.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 02.19.2025 - EX-99.1 EX-99.1
• 02.19.2025 - 8-K Current report
• 01.13.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 01.06.2025 - 8-K Current report
• 01.06.2025 - 8-K Current report